Saturn V Capital Management LP Q3 2025 Filing
Filed November 14, 2025
Portfolio Value
$456.0B
Holdings
17
Report Date
Q3 2025
Filing Type
13F-HR
All Holdings (17 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ABVXABIVAX SA | 801,224 | $68.0B | 14.92% | |
| 2 | AMLXAMYLYX PHARMACEUTICALS INC | 4,604,878 | $62.6B | 13.72% | |
| 3 | JAZZJAZZ PHARMACEUTICALS PLC | 300,610 | $39.6B | 8.69% | |
| 4 | DYNDYNE THERAPEUTICS INC | 2,674,469 | $33.8B | 7.42% | |
| 5 | COGTCOGENT BIOSCIENCES INC | 2,025,041 | $29.1B | 6.38% | |
| 6 | PCVXVAXCYTE INC | 788,441 | $28.4B | 6.23% | |
| 7 | CELCCELCUITY INC | 473,828 | $23.4B | 5.13% | |
| 8 | CGONCG ONCOLOGY INC | 579,895 | $23.4B | 5.12% | |
| 9 | IRONDISC MEDICINE INC | 340,897 | $22.5B | 4.94% | |
| 10 | PHVSPHARVARIS N V | 886,332 | $22.1B | 4.85% | |
| 11 | XENEXENON PHARMACEUTICALS INC | 503,701 | $20.2B | 4.44% | |
| 12 | CNTACENTESSA PHARMACEUTICALS PLC | 734,539 | $17.8B | 3.91% | |
| 13 | MRUSMERUS N V | 184,135 | $17.3B | 3.80% | |
| 14 | LENZLENZ THERAPEUTICS INC | 368,176 | $17.1B | 3.76% | |
| 15 | OCULOCULAR THERAPEUTIX INC | 1,151,686 | $13.5B | 2.95% | |
| 16 | MNPRMONOPAR THERAPEUTICS INC | 155,370 | $12.7B | 2.78% | |
| 17 | NAMSNEWAMSTERDAM PHARMA COMPANY | 153,147 | $4.4B | 0.96% |